Literature summary extracted from
Hurt, D.E.; Widom, J.; Clardy, J.
Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor (2006), Acta Crystallogr. Sect. D, 62, 312-323.
Application
EC Number |
Application |
Comment |
Organism |
---|
1.3.98.1 |
additional information |
species-specific preferential inhibitor binding, different binding mode for the same inhibitor in the two catalytically identical enzymes human DHODH and Plasmodium DHODH |
Plasmodium falciparum |
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
1.3.98.1 |
into vector pRSET and expressed in either freshly transformed or glycerol stocked Escherichia coli BL21-CodonPlus (DE3)-RIL |
Plasmodium falciparum |
Crystallization (Commentary)
EC Number |
Crystallization (Comment) |
Organism |
---|
1.3.98.1 |
by sitting-drop vapor-diffusion technique, to 2.4 A resolution |
Plasmodium falciparum |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
1.3.98.1 |
additional information |
brequinar and DPC-AE661100 have no effect, even at a concentration of 1 mM |
Plasmodium falciparum |
|
KM Value [mM]
EC Number |
KM Value [mM] |
KM Value Maximum [mM] |
Substrate |
Comment |
Organism |
Structure |
---|
1.3.98.1 |
0.0131 |
- |
2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone |
at saturating concentration of dihydroorotate |
Plasmodium falciparum |
|
Molecular Weight [Da]
EC Number |
Molecular Weight [Da] |
Molecular Weight Maximum [Da] |
Comment |
Organism |
---|
1.3.98.1 |
50000 |
- |
gel filtration |
Plasmodium falciparum |
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
1.3.98.1 |
Plasmodium falciparum |
Q08210 |
synthetic construct |
- |
Purification (Commentary)
EC Number |
Purification (Comment) |
Organism |
---|
1.3.98.1 |
soniciation and gel filtration |
Plasmodium falciparum |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
1.3.98.1 |
dihydroorotate + 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone |
- |
Plasmodium falciparum |
orotate + reduced 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone |
- |
? |
|
1.3.98.1 |
dihydroorotate + 2,6-dichloroindophenol |
- |
Plasmodium falciparum |
orotate + reduced 2,6-dichloroindophenol |
- |
? |
|
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
1.3.98.1 |
DHODH |
- |
Plasmodium falciparum |
Turnover Number [1/s]
EC Number |
Turnover Number Minimum [1/s] |
Turnover Number Maximum [1/s] |
Substrate |
Comment |
Organism |
Structure |
---|
1.3.98.1 |
additional information |
- |
2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone |
at saturating concentration of dihydroorotate |
Plasmodium falciparum |
|
1.3.99.11 |
6.15 |
- |
2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone |
at saturating concentration of dihydroorotate |
Plasmodium falciparum |
|